A postdoctoral position is available in the UMR242 of University of Strasbourg in the group “GPCR&cardiobiology”. In the course of an ERA-NET, ERA-CVD project aiming to develop new therapeutic strategy against cardiotoxicity induced by anticancer agents, the candidate will be in charge on the elaboration and evaluation of the novel cardio-protective therapeutics in human stem cell-based in vitro models and in in vivo mouse models. He/She will. He/She will also be involved in the identification of the molecular pathways involved in anticancer drug-induced HF. The candidate must have an interdisciplinary background in molecular and cell biology.
Due to the highly pluridisciplinary project, the successful candidate should hold a PhD in molecular & cellular biology, or chemical-biology and must have a high-quality expertise in standard biochemical &cellular assays. She will learn animal experimentation during her post-doctoral training.